关注
Georgie Bowyer
Georgie Bowyer
Post-Doctoral Research Associate, University of Cambridge
在 cam.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
A monovalent chimpanzee adenovirus Ebola vaccine boosted with MVA
K Ewer, T Rampling, N Venkatraman, G Bowyer, D Wright, T Lambe, ...
New England Journal of Medicine 374 (17), 1635-1646, 2016
3012016
Local and systemic responses to SARS-CoV-2 infection in children and adults
M Yoshida, KB Worlock, N Huang, RGH Lindeboom, CR Butler, ...
Nature 602 (7896), 321-327, 2022
2392022
Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults
C Ogwang, D Kimani, NJ Edwards, R Roberts, J Mwacharo, G Bowyer, ...
Science translational medicine 7 (286), 286re5-286re5, 2015
1622015
Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals
SH Hodgson, KJ Ewer, CM Bliss, NJ Edwards, T Rampling, ...
The Journal of infectious diseases 211 (7), 1076-1086, 2015
1572015
Malaria-induced interferon-γ drives the expansion of Tbethi atypical memory B cells
N Obeng-Adjei, S Portugal, P Holla, S Li, H Sohn, A Ambegaonkar, ...
PLoS pathogens 13 (9), e1006576, 2017
1512017
A monovalent chimpanzee adenovirus Ebola vaccine—preliminary report
T Rampling, K Ewer, G Bowyer, D Wright, E Imoukhuede, R Payne, ...
New England Journal of Medicine, 2015
1392015
Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara …
T Rampling, KJ Ewer, G Bowyer, CM Bliss, NJ Edwards, D Wright, ...
The Journal of infectious diseases 214 (5), 772-781, 2016
882016
First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
AB Tiono, I Nébié, N Anagnostou, AS Coulibaly, G Bowyer, E Lam, ...
PloS one 13 (12), e0208328, 2018
822018
Activation-induced Markers Detect Vaccine-Specific CD4+ T Cell Responses Not Measured by Assays Conventionally Used in Clinical Trials
G Bowyer, T Rampling, J Powlson, R Morter, D Wright, AVS Hill, KJ Ewer
Vaccines 6 (3), 50, 2018
782018
Prime and target immunization protects against liver-stage malaria in mice
A Gola, D Silman, AA Walters, S Sridhar, S Uderhardt, AM Salman, ...
Science translational medicine 10 (460), eaap9128, 2018
752018
Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations
D Kimani, YJ Jagne, M Cox, E Kimani, CM Bliss, E Gitau, C Ogwang, ...
Molecular Therapy 22 (11), 1992-2003, 2014
722014
Safety and immunogenicity of a heterologous prime-boost Ebola virus vaccine regimen in healthy adults in the United Kingdom and Senegal
N Venkatraman, BP Ndiaye, G Bowyer, D Wade, S Sridhar, D Wright, ...
The Journal of infectious diseases 219 (8), 1187-1197, 2019
682019
Safety and efficacy of novel malaria vaccine regimens of RTS, S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP
T Rampling, KJ Ewer, G Bowyer, NJ Edwards, D Wright, S Sridhar, ...
NPJ vaccines 3 (1), 49, 2018
552018
Viral vector malaria vaccines induce high-level T cell and antibody responses in West African children and infants
CM Bliss, A Drammeh, G Bowyer, GS Sanou, YJ Jagne, O Ouedraogo, ...
Molecular Therapy 25 (2), 547-559, 2017
552017
A review of phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?
T Lambe, G Bowyer, KJ Ewer
Philosophical Transactions of the Royal Society B: Biological Sciences 372 …, 2017
512017
Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
CM Bliss, G Bowyer, NA Anagnostou, T Havelock, CM Snudden, H Davies, ...
Scientific reports 8 (1), 3390, 2018
502018
HLA-E: exploiting pathogen-host interactions for vaccine development
HR Sharpe, G Bowyer, S Brackenridge, T Lambe
Clinical & Experimental Immunology 196 (2), 167-177, 2019
362019
CXCR3+ T Follicular Helper Cells Induced by Co-Administration of RTS,S/AS01B and Viral-Vectored Vaccines Are Associated With Reduced Immunogenicity and …
G Bowyer, A Grobbelaar, T Rampling, N Venkatraman, D Morelle, ...
Frontiers in immunology 9, 1660, 2018
352018
Safety and immunogenicity of malaria vectored vaccines given with routine expanded program on immunization vaccines in Gambian infants and neonates: a randomized controlled trial
VA Mensah, S Roetynck, EK Kanteh, G Bowyer, A Ndaw, F Oko, CM Bliss, ...
Frontiers in immunology 8, 1551, 2017
322017
Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M™
N Venkatraman, N Anagnostou, C Bliss, G Bowyer, D Wright, ...
Vaccine 35 (45), 6208-6217, 2017
322017
系统目前无法执行此操作,请稍后再试。
文章 1–20